Gastrointestinal Cancer News

Cancer survivors with a high disease-related financial burden appeared more susceptible to depression, poor quality of life and fear of recurrence, according to the results of cross-sectional study.

The overall incidence and mortality rates for cancer have decreased over the years, according to the newly released Annual Report to the Nation on the Status of Cancer.

The identification of high microsatellite instability in tumors has led to advances in determining prognosis and response to therapy among patients with colorectal cancer, according to David H. Ilson, MD, PhD, a medical oncologist at Memorial Sloan Kettering Cancer Center and a professor of medicine at Weill Cornell Medical College.

Patients with hepatocellular carcinoma admitted to the hospital on the weekend had an increased likelihood for mortality vs. patients admitted on a weekday, according to data presented at the Society of Hospital Medicine Annual Meeting 2016.

Celsion Corporation announced the launch of the OPTIMA study for primary hepatocellular carcinoma in China, which will investigate the safety and efficacy of ThermoDox plus radiofrequency ablation, according to a press release.

The lack of a dose–response relationship between hospital adherence to National Quality Forum colon cancer quality metrics and survival suggested these metrics may be poor quality measures, according to data presented during the plenary session of the Society for Surgical Oncology Annual Cancer Symposium.

In the SHELTER clinical trial, patients with hepatocellular carcinoma treated with Nexavar in combination with resminostat had efficacious treatment rates vs. resminostat alone, according to data published in the Journal of Hepatology.

A treatment regimen of nanoliposomal irinotecan, fluorouracil and folinic acid appeared to prolong survival in patients with metastatic pancreatic cancer previously treated with gemcitabine-based chemotherapy, according to the results of a randomized, open-label phase 3 trial.

An increasing level of obesity was found to be associated with higher mortality among Western patients with pancreatic cancer in a systematic review and meta-analysis.

In this video with Healio.com, Theodore S. Hong, MD, director of gastrointestinal radiation oncology at Massachusetts General Hospital, discusses ongoing research in rectal cancer.